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Continuous predictors are routinely encountered when developing a prognostic model. Investigators, who are
often non-statisticians, must decide how to handle continuous predictors in their models. Categorising continu-
ous measurements into two or more categories has been widely discredited, yet is still frequently done because of
its simplicity, investigator ignorance of the potential impact and of suitable alternatives, or to facilitate model
uptake. We examine three broad approaches for handling continuous predictors on the performance of a prog-
nostic model, including various methods of categorising predictors, modelling a linear relationship between the
predictor and outcome and modelling a nonlinear relationship using fractional polynomials or restricted cubic
splines. We compare the performance (measured by the c-index, calibration and net beneﬁt) of prognostic
models built using each approach, evaluating them using separate data from that used to build them. We show
that categorising continuous predictors produces models with poor predictive performance and poor clinical
usefulness. Categorising continuous predictors is unnecessary, biologically implausible and inefﬁcient and
should not be used in prognostic model development. © 2016 The Authors. Statistics in Medicine Published by
John Wiley & Sons Ltd.
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1. Introduction
Categorising continuous measurements in regression models has long been regarded as problematic
(e.g., biologically implausible particularly when dichotomising), highly inefﬁcient and unnecessary
[1–5]. In the context of clinical prediction, investigators developing new prognostic models frequently
categorise continuous predictors into two or more categories [6]. Categorisation is often carried out with
no apparent awareness of its consequences or in a misguided attempt to facilitate model interpretation,
use and uptake. However, categorisation causes a loss of information, and therefore reduces the statisti-
cal power to identify a relationship between a continuous measurement and patient outcome [7]. As
studies developing new prognostic models are already generally quite small, it seems unwise to discard
any information [6,8]. Despite the numerous cautions and recommendations not to categorise continuous
measurements, there have been relatively few quantitative assessments of the impact of the choice of
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G. S. COLLINS ET AL.Determining the functional form of a variable is an important, yet often overlooked step in modelling
[10]. It is often insufﬁcient to assume linearity, and categorising continuous variables should be avoided.
Alternative approaches that allow more ﬂexibility in the functional form of the association between
predictors and outcome should be considered, particularly if they improve model ﬁt and model predictions
[11–13]. Two commonly used approaches are fractional polynomials and restricted cubic splines [14,15].
However, few studies have examined how the choice of approach for handling continuous variables affects
the performance of a prognostic model. Two single case studies demonstrated that dichotomising contin-
uous predictors resulted in a loss in information and a decrease in the predictive ability of a prediction
model [1,16]. However, neither study was exhaustive, and both studies only examined the impact on
model performance using the same data that the models were derived from. In a more recent study, Nieboer
and colleagues compared the effect of using log transformations, fractional polynomials and restricted cu-
bic splines against retaining continuous predictors as linear on the performance of logistic-based prediction
models, but they did not also examine models that categorised one or more continuous predictors [9].
When developing a new prognostic model, investigators can broadly choose to (i) dichotomise, or
more generally categorise, a continuous predictor using one or more cut-points; (ii) leave the predictor
continuous but assume a linear relationship with the outcome; or (iii) leave the predictor continuous but
allow a nonlinear association with the outcome, such as by using fractional polynomials or restricted
cubic splines. How continuous measurements are included will affect the generalisability and transport-
ability of the model [17]. A key test of a prognostic model is to evaluate its performance on an entirely
separate data set [18]. It is therefore important that the associations are appropriately modelled, to
improve the likelihood that the model will predict sufﬁciently well using data with different case-mix.
The aim of this article is to quantitatively illustrate the impact of the choice of approach for handling
continuous predictors on the apparent performance (based on the development data set) and validation
performance (in a separate data set) of a prognostic model.
2. Methods
2.1. Study data: The Health Improvement Network
The Health Improvement Network (THIN) is a large database of anonymised electronic primary care
records collected at general practice surgeries around the United Kingdom (England, Scotland, Wales
and Northern Ireland). The THIN database contains medical records on approximately 4% of the United
Kingdom population. Clinical information from over 2 million individuals (from 364 general practices)
registered between June 1994 and June 2008 form the data set. The data have previously been used in
the external validation of a number of risk prediction models, including those considered in this study
[19–26]. There are some missing data for the predictors of systolic blood pressure, body mass index
and cholesterol. For simplicity and convenience, we have used an imputed data set used in published
external validation studies (details on the imputation strategy are reported elsewhere [20,27]).
2.2. Prognostic models
We used Cox regression to develop prognostic models that predict the 10-year risk of cardiovascular dis-
ease and 10-year risk of hip fracture. We split the THIN database geographically by pulling out two
cohorts: general practices from England and general practices from Scotland. Data from the England
cohort were used to develop the models, whilst data from Scotland were used to validate the model. Using
data for 1,803,778 patients (men and women) from England (with 80,880 outcome events) to develop car-
diovascular prognostic models. Model performance was evaluated on 110,934 patients from Scotland
(with 4688 outcome events). Similarly, 980,465 women (with 7721 outcome events) in the THIN data-
base from England were used to develop hip fracture models. The model performance was evaluated
on data from 61,563 women from Scotland (with 565 outcome events). All data come from the same un-
derlying computer system used to collect the patient level data, and thus splitting this large database geo-
graphically is a weak form of external validation (sometimes referred to as narrow validation), although
given the health systems in the two countries are ultimately the same the case-mix is not dissimilar. In this
instance, the validation is closer to an assessment of reproducibility than transportability [18].
For convenience and simplicity, the models were developed using a subset of variables that were
chosen from the total list of predictors contained in the QRISK2 [28] and QFracture [29] risk prediction
models. The cardiovascular disease models used age (continuous), sex (binary), family history of cardio-
vascular disease (binary), serum cholesterol (continuous), systolic blood pressure (continuous), body© 2016 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. Statist. Med. 2016
G. S. COLLINS ET AL.mass index (continuous) and treated hypertension (binary). The hip fracture models used age (continu-
ous), body mass index (continuous), Townsend score (categorical), diagnosis of asthma (binary) and
prescription of tricyclic antidepressants (binary). Table I shows the distribution of the model variables
in the THIN data set for both outcomes.
2.3. Resampling strategy
A resampling study was performed to examine the impact of different strategies for handling continuous
predictors in the development of prognostic models on the performance of the model when evaluated in
a separate data set.
Two hundred samples were randomly drawn (with replacement) from the THIN data set so that the
number of events in each sample was ﬁxed at 25, 50, 100 and 2000. Individuals in each sample were cho-
sen by sampling a constant fraction of those who experienced the event and those who did not, according
to the overall proportion of events in the THIN data set, for the corresponding prognostic model outcome
(cardiovascular disease or hip fracture). Models were developed for each sample as described in Sections
2.2 and 2.4. Model performance (Section 2.5) was evaluated on the same data used to derive the model, to
give the apparent performance, and on separate data, for validation performance (Section 2.1).
2.4. Approaches for handling continuous predictors
We considered three broad approaches for handling continuous predictors:
1. Categorise each continuous predictor into equally sized groups, using the median value of the predic-
tor to form two groups, the tertile values to form three groups, the quartile values to form four groups
or the quintile values to form ﬁve groups. We further categorised the age predictor by grouping indi-
viduals into 5-year or 10-year age intervals. We also categorised the continuous predictors based on
‘optimal’ cut-points, using a cut-point that minimised the P-value from the logrank test for over 80%
of the observations (the lower and upper 10% of observations removed) [30].
2. Model each continuous predictor by assuming that it has a linear relationship with the outcome.
3. Model each continuous predictor by assuming that it has a non-linear relationship with the outcome,
using fractional polynomials [14] and restricted cubic splines [15]. Fractional polynomials are a set of
ﬂexible power transformations that describe the relationship between a continuous predictor and the
outcome. Fractional polynomials of degree one (FP1) and two (FP2) are deﬁned as
FP1 xð Þ ¼ β1xp;
FP2 xð Þ ¼ β1x
p1 þ β2xp2 ; p1≠p2
β1x
p1 þ β2xp2 lnx; p1 ¼ p2 ¼ p

where the powers p, p1,p2∈S={2, 1,0.5, 0, 0.5, 1, 2, 3} and x0 = ln x. We used the multivariable
fractional polynomial (MFP) procedure in R to model potentially nonlinear effects while performingTable I. Characteristics of the individuals in the THIN data set, used as predictors in the developed prognos-
tic models; SD: standard deviation.
Variable Cardiovascular disease Hip fracture
Development
(England)
(n= 1,803,778)
Validation
(Scotland)
(n= 110,934)
Development
(England)
(n= 980,465)
Validation
(Scotland)
(n= 61,563)
Mean age in years (SD) 48.6 (14.1) 48.9 (14.0) 50.8 (15.3) 50.1 (14.9)
Men 922,913 (51.2%) 62,321 (56.2%) — —
Family history of cardiovascular disease 74,668 (4.1%) 4,268 (3.8%) — —
Mean serum cholesterol (SD) 5.5 (1.2) 5.5 (1.2) — —
Mean systolic blood pressure (SD) 131.8 (20.3) 131.6 (20.2) — —
Mean body mass index (SD) 26.3 (4.4) 26.3 (4.5) 26.1 (4.9) 26.5 (5.1)
Treated for hypertension 96,634 (5.4%) 6,223 (5.6%) — —
Diagnosis of asthma — — 84,279 (8.6%) 5,207 (8.5%)
History of falls — — 26,124 (2.7%) 1,016 (1.7%)
Prescription of tricyclic antidepressants — — 51,849 (5.3%) 3,528 (5.7%)
© 2016 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. Statist. Med. 2016
G. S. COLLINS ET AL.variable selection [31]. MFP formally tests for deviations from linearity using fractional polynomials. It
incorporates a closed test procedure that preserves the ‘familywise’ nominal signiﬁcance level. The
default FP2 with signiﬁcance level of 0.05 was chosen to build the prognostic models. The restricted cu-
bic splines method places knots along the predictor value range and between two adjacent knots, where
the association between the predictor and the outcome is modelled using a cubic polynomial. Beyond the
outer two knots, the relationship between the predictor and outcome is modelled as a linear association.
Three to ﬁve knots are often sufﬁcient to model the complex associations that are usually based on the
percentiles of the predictor values. We used the rcs function in the rms package in R [32]. Prior to
conducting the simulations, preliminary analyses suggested that four degrees of freedom should be used
to model each continuous predictor with fractional polynomials (i.e., FP2 models) and that three knots
should be used in the restricted cubic splines approach. The models with the highest degrees of freedom
(df) were those categorising the continuous predictors into ﬁfths (CVD: df = 19, Hip fracture: df = 11),
model using fractional polynomials also had a maximum potential degrees of freedom also of 19 and
11 for the CVD and hip fracture models respectively. The fewest degrees of freedom were used by
the models that assumed a linear relationship with the outcome, those dichotomising (CVD: df =7;
Hip fracture: df = 5), see Supplementary Table 1.
Figure 1 shows how the relationship between the continuous predictors (age, systolic blood pres-
sure, body mass index and total serum cholesterol) and cardiovascular disease when estimated,
assuming linearity, nonlinearity (fractional polynomials and restricted cubic splines) and using
categorisation (Supplementary Figure 1 shows the corresponding relationship for continuous age
and body mass index with hip fracture). Age is one of the main risk factors for many diseases,
including cardiovascular disease [33] and hip fractures [34]; we therefore examined models whereby
all continuous predictors apart from age were assumed linear, whilst age was included using the
approaches described above.
All of the continuous predictors in the development and validation data sets were centred and scaled
before modelling. Scaling and centring reduce the chance of numerical underﬂow or overﬂow, which
can cause inaccuracies and other problems in model estimation [13]. The values used for transformation
were obtained from the development data set and were also applied to the validation data set.2.5. Performance measures
Model performance was assessed in terms of discrimination, calibration, overall model performance and
clinical utility. Discrimination is the ability of a prognostic model to differentiate between people with
different outcomes, such that those without the outcome have a lower predicted risk than those with
the outcome. The survival models in this study were based on the time-to-event. Discrimination was thus
evaluated using Harrell’s c-index, which is a generalisation of the area under the receiver operating char-
acteristic curve for binary outcomes (e.g. logistic regression) [35,36].
We graphically examined the calibration of the models at a single time point, 10 years, using the val.
surv function in the rms library in R. For each random sample, hazard regression with linear splines was
used to relate the predicted probabilities from the models at 10 years to the observed event times (and
censoring indicators). The actual event probability at 10 years was estimated as a function of the estimate
event probability at 10 years. We investigated the inﬂuence of the approach used to handle continuous
predictors on calibration by overlaying plots of observed outcomes against predicted probabilities for
each of the 200 random samples.
We evaluated the clinical usefulness, or net beneﬁt, of the models using decision curve analysis [37].
Net beneﬁt is the difference between the number of true-positive results and the number of false-positive
results, weighted by a factor that gives the cost of a false-positive relative to a false-negative result [38],
and is deﬁned as:
Net Benefit ¼ True Positives
n
 False positives
n
pt
1 pt
 
:
The numbers of true and false positives were estimated using the Kaplan–Meier estimates of the
percentage surviving at 10 years among those with calculated risks greater than the threshold probability.
n is the total number of people. pt is the threshold on the probability scale that deﬁnes high risk and is
used to weight false positives to false negative results. To calculate the net beneﬁt for survival time data© 2016 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. Statist. Med. 2016
Figure 1. Continuous predictors from the THIN development data set. Models developed to predict cardiovas-
cular disease using the (orange) fractional polynomial approach with four degrees of freedom, (black) restricted
cubic spline approach using three knots, (blue) dichotomising at the median predictor value approach, (green)
categorising into ﬁve equally sized groups approach and (red) linear approach.
G. S. COLLINS ET AL.subject to censoring [39], we deﬁned x=1 if an individual had a predicted probability from the
model≥pt (the threshold probability), and x=0 otherwise. S(t) is the Kaplan–Meier survival probability
at time t (t = 10 years) and n is the number of individuals in the data set. The number of true positives is
given by [1 (S(t) | x=1)] ×P(x=1) ×n and the number of false positives by (S(t) | x=1)×P(x=1)×n. A
decision curve was produced by plotting across a range of pt values.
3. Results
Tables II and III show the mean (standard deviation) of the c-index over the 200 samples (each contain-
ing 25, 50, 100 and 2000 events) for the models produced by each approach that predict the hip fracture
and cardiovascular outcomes, respectively. For the hip fracture models, there was a large difference of
0.1 between the mean c-index produced by the approaches that did not categorise the continuous predic-
tors and the approach that dichotomised the continuous predictors at the median. The same c-index dif-
ference was observed in the apparent performance (i.e. the development performance) and the
geographical validation performance. A similar pattern was observed for other performance measures
including the D-statistic [40], R2 [41] and Brier score (see Supplementary Tables 2–7). The differences
in all the measures (c-index, D-statistic, R2 and Brier score [42]) all favoured the approaches that kept
the variables continuous. The approaches that assumed a linear relationship between the predictor and
outcome and the approaches that used either fractional polynomials or restricted cubic splines had sim-
ilar results for all of the performance measures. The variability (as reﬂected in the SD) in the four model© 2016 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. Statist. Med. 2016
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G. S. COLLINS ET AL.performance metrics was small relative to the mean value for all of the methods of handling continuous
predictors.
Similar patterns in model performance were observed in the cardiovascular models. For example, a
difference of 0.055 in the c-index between the approaches that assumed a linear or nonlinear relationship
between the predictor and outcome and the approach that dichotomised at the median predictor value
was observed in both the apparent performance and geographical validation.
Figure 2 shows the geographical validation calibration plots for the cardiovascular models. The
models using fractional polynomials or restricted cubic splines were better calibrated than the models
produced by other approaches, including the models that assumed a linear relationship between the
predictor and outcome. A similar pattern was observed in the hip fracture models, although there was
more similarity between the linear and nonlinear approaches (see Supplemental Figure 7).
Figure 3 shows the distribution of the predicted 10-year cardiovascular risk for a subset of the
approaches. The approaches that kept the measurements continuous (linear, fractional polynomial and
restricted cubic splines) showed similar predicted risk spreads. The approaches that categorised the
continuous predictors showed a noticeably wide predicted risk spread in those who did not experience
the outcome, which was widest when the predictor was dichotomised, and showed a noticeable narrow
spread for those who did experience the outcome. As the number of categories increases the spread of
predicted risk in those who did not have an event decreases, whilst the spread of predicted risk in those
who did have an event increases.
Models developed with smaller sample sizes (25, 50 and 100 events) showed higher performance
measure values when they were evaluated using the development data set than the models developedFigure 2. Calibration plots of cardiovascular disease risk in the validation cohort (2000 events).
© 2016 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. Statist. Med. 2016
Figure 3. Boxplot of the predicted cardiovascular disease risks in the validation cohort (2000 events).
G. S. COLLINS ET AL.with 2000 events. This pattern was observed for both the hip fracture and cardiovascular disease models,
regardless of the how continuous predictors were included in the models. In contrast, lower values were
observed in the geographical validation of models developed with smaller sample sizes than the models
developed with 2000 events, suggesting overﬁtting. Similarly, models developed with fewer events
showed worse calibration on the geographical validation data than the models developed with 2000
events. The models developed by categorising continuous predictors showed the greatest variability in
performance.
Table IV shows the clinical consequences of the different strategies for handling the continuous pre-
dictors in the cardiovascular models, using dichotomising at the median predictor value as the reference
method. Similar ﬁndings were observed in the hip fracture models. Over a range of probability thresh-
olds (e.g. 0.09 to 0.2), an additional net 5 to 10 cardiovascular disease cases per 1000 were found during
geographical validation if models that implemented fractional polynomials or restricted cubic splines
were used, rather than models that dichotomised all of the continuous predictors at the median without
conducting any unnecessary treatment. For models that categorised continuous predictors, more addi-
tional cases per 1000 found as the number of categories increases. The models that used fractionalTable IV. Range of additional net cases per 1000 found when using each approach for handling continuous
predictors, compared with categorising all of the continuous predictors at the median. Models developed using
2000 outcome events. Range of thresholds 0.09 to 0.2 for cardiovascular disease and 0.01 to 0.05 for hip
fracture.
Model Cardiovascular disease Hip fracture
Development Validation Development Validation
Linear 6 to 11 5 to 10 4 to 6 5 to 7
Fractional polynomials 7 to 11 6 to 10 4 to 6 5 to 7
Restricted cubic splines 7 to 11 6 to 10 4 to 6 5 to 7
5-year age categories 6 to 10 6 to 9 4 to 6 4 to 7
10-year age categories 6 to 10 5 to 9 2 to 5 3 to 6
Thirds 2 to 6 1 to 5 1 to 3 1 to 3
Fourths 4 to 8 3 to 7 1 to 4 2 to 5
Fifths 5 to 9 4 to 8 2 to 5 3 to 6
© 2016 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. Statist. Med. 2016
G. S. COLLINS ET AL.polynomials or restricted cubic splines, or that assumed a linear relationship between the predictor and
outcome all showed a higher net beneﬁt, over a range of thresholds (0.09 to 0.2), than the categorising
approaches (see Supplementary Figure 9).
4. Discussion
We examined the impact of the choice of approach for handling continuous predictors when developing
a prognostic model and evaluating it on a separate data set. We developed models using data sets of
varying size to illustrate the inﬂuence of sample size. The predictive ability of the models was evaluated
on a large geographical validation data set, using performance measures that have been recommended
for evaluation and reporting [43,44].
We have demonstrated that categorising continuous predictors, particularly dichotomising at the me-
dian value of the predictor, produces models that have substantially weaker predictive performance than
models produced with alternative approaches that retain the predictor on a continuous scale [1]. It is not
surprising that categorising continuous predictors leads to poor models, as it forces an unrealistic, bio-
logically implausible and ultimately incorrect (step) relationship onto the predictor and discard informa-
tion. It may appear to be sensible to use two or more quantiles (or similar apparently meaningful cut-
points, such as a particular age) to categorise an outcome into three or more groups, but this approach
does not reﬂect the actual predictor–outcome relationship. Individuals whose predictor values are similar
but are either side of a cut-point are assigned different levels of risk, which has clear implications on how
the model will be used in clinical practice. The fewer the cut-points, the larger the difference in risk
between two individuals with similar predictor values immediately either side of a cut-point. We
observed only small differences between the methods that retained the variables as continuous (assum-
ing linearity or nonlinearity). Larger differences would be expected if the relationship between a contin-
uous variable and the outcome were markedly nonlinear.
Continuous predictors are often categorised as the approach is intuitive, simple to implement and
researchers may expect it to improve model use and uptake. However, categorising comes at a sub-
stantial cost to the predictive performance. We believe that this cost is detrimental and counterpro-
ductive, as the resulting models have weak predictive accuracy and are unpopular for clinical use.
If ease of use is required, we recommend leaving predictors as continuous during modelling and
instead simplifying the ﬁnal model, using a points system to allow ﬁner calculation of an individ-
ual’s risk [45–47].
We focused on exploring the differences in the predictive performance of models produced by each
approach for handling continuous predictors. Focusing on a ﬁxed and small number of variables, we
circumvented issues around variable selection procedures for which we anticipate the differences in per-
formance to be more marked. Using restricted cubic splines on very small data sets may produce wiggly
functions, and fractional polynomials can result in poorly estimated tails. Both problems lead to unstable
models that have poor predictive ability when evaluated on separate data in a geographical validation.
We observed very little difference in model performance when using either fractional polynomials or re-
stricted cubic splines. Similarly, when a data set is small, the centile values for dichotomising or
categorising continuous predictor values may vary considerably from sample to sample, again leading
to unstable models and poor predictive performance. We did, however, also examine the inﬂuence of
smaller sample sizes on model performance and observed greater variability in model performance in
small samples with few outcome events than in larger samples. Furthermore, the apparent performance
on smaller data sets was higher compared to using larger data set (which decreased as sample size
increased), but at the expense of poorer performance in the geographical validation, where recent guid-
ance suggests that a minimum of 100 events are required [48].
Systematic reviews have highlighted numerous methodological ﬂaws, including small sample size,
missing data and inappropriate statistical analyses in studies that describe the development or valida-
tion of prognostic models [6,8,49–52]. Contributing to why many studies have methodological short-
comings is because it is generally easy to create a (poorly performing) prognostic model. A model
that has been developed using poor methods is likely to produce overoptimistic and misleading
performance. As noted by Andrew Vickers, ‘we have a data set, and a statistical package, and
add the former to the latter, hit a few buttons and voila, we have another paper’ [53]. It is therefore
both unsurprising and fortunate that most prognostic models never get used. However, some of these
poorly performing or suboptimal prognostic models will undoubtedly be used, which may have unde-
sirable clinical consequences. We have clearly demonstrated that categorising continuous predictor© 2016 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. Statist. Med. 2016
G. S. COLLINS ET AL.outcomes is an inadequate approach. Investigators who wish to develop a new prognostic model for
use on patients that is ﬁt for purpose should follow the extensive methodological guidance on model
building that discourages categorisation and use an approach that keeps the outcome continuous
[11–13].Acknowledgements
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